Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccination

References

• Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34:Suppl 1 S1 - 3; http://dx.doi.org/10.1016/S1386-6532(05)00384-7; PMID: 16461208
   PubMed Web of Science ®Google Scholar
• Lehman EM, Wilson ML. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer 2009; 124:690 - 7; http://dx.doi.org/10.1002/ijc.23937; PMID: 18973270
   PubMed Web of Science ®Google Scholar
• Specialist Panel on Chronic Hepatitis B in the Middle East. A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East. J Viral Hepat 2012; 19:9 - 22; http://dx.doi.org/10.1111/j.1365-2893.2011.01511.x; PMID: 22187943
   PubMed Web of Science ®Google Scholar
• Raimondo G, Caccamo G, Filomia R, Pollicino T. Occult HBV infection. Semin Immunopathol 2013; 35:39 - 52; http://dx.doi.org/10.1007/s00281-012-0327-7; PMID: 22829332
   PubMed Web of Science ®Google Scholar
• Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007; 46:160 - 70; http://dx.doi.org/10.1016/j.jhep.2006.10.007; PMID: 17112622
   PubMed Web of Science ®Google Scholar
• Hamkar R, Aghakhani A, Soufian S, Banifazl M, Ghavami N, Nadri M, Sofian M, Ahmadi F, Razeghi E, Eslamifar A, et al. Surface gene mutations of hepatitis B virus among high-risk patients with occult hepatitis B virus infection. Diagn Microbiol Infect Dis 2010; 66:285 - 91; http://dx.doi.org/10.1016/j.diagmicrobio.2009.10.006; PMID: 19903586
   PubMed Web of Science ®Google Scholar
• van Hemert FJ, Zaaijer HL, Berkhout B, Lukashov VV. Occult hepatitis B infection: an evolutionary scenario. Virol J 2008; 5:146; http://dx.doi.org/10.1186/1743-422X-5-146; PMID: 19077239
   PubMed Web of Science ®Google Scholar
• Bläckberg J, Kidd-Ljunggren K. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 2000; 33:992 - 7; http://dx.doi.org/10.1016/S0168-8278(00)80134-8; PMID: 11131464
   PubMed Web of Science ®Google Scholar
• Mu S-C, Lin Y-M, Jow G-M, Chen B-F. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 2009; 50:264 - 72; http://dx.doi.org/10.1016/j.jhep.2008.09.017; PMID: 19070923
   PubMed Web of Science ®Google Scholar
• Su H, Zhang Y, Xu D, Wang B, Zhang L, Li D, Xiao D, Li F, Zhang J, Yan Y. Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China. PLoS One 2013; 8:e70768; http://dx.doi.org/10.1371/journal.pone.0070768; PMID: 23951004
   PubMed Web of Science ®Google Scholar
• Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM. High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J Hepatol 2012; 57:515 - 21; http://dx.doi.org/10.1016/j.jhep.2012.04.021; PMID: 22617152
   PubMed Web of Science ®Google Scholar
• Demir M, Serin E, Göktürk S, Ozturk NA, Kulaksizoglu S, Ylmaz U. The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients. Eur J Gastroenterol Hepatol 2008; 20:668 - 73; http://dx.doi.org/10.1097/MEG.0b013e3282f55e1e; PMID: 18679070
   PubMed Web of Science ®Google Scholar
• Elrashidy H, Elbahrawy A, El-Didamony G, Mostafa M, George NM, Elwassief A, Saeid Mohamed AG, Elmestikawy A, Morsy MH, Hashim A, et al. Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents. Hum Vaccin Immunother 2013; 9:2002 - 6; http://dx.doi.org/10.4161/hv.25426; PMID: 23787761
   PubMed Web of Science ®Google Scholar
• Leonardi S, Vitaliti G, Garozzo MT, Miraglia del Giudice M, Marseglia G, La Rosa M. Hepatitis B vaccination failure in children with diabetes mellitus? The debate continues. Hum Vaccin Immunother 2012; 8:448 - 52; http://dx.doi.org/10.4161/hv.19107; PMID: 22370513
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Onoue M, Inui A, Kosugi T. Serial changes in titers of antibody to hepatitis B surface antigen after immunization of infants born to mothers with hepatitis B e antigen. J Pediatr Gastroenterol Nutr 1996; 23:270 - 4; http://dx.doi.org/10.1097/00005176-199610000-00011; PMID: 8890077
   PubMed Web of Science ®Google Scholar
• Jafarzadeh A, Montazerifar SJ. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth. J Ayub Med Coll Abbottabad 2006; 18:4 - 9; PMID: 17591001
   PubMedGoogle Scholar
• Zanetti AR, Mariano A, Romanò L, D’Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, et al, Study Group. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366:1379 - 84; http://dx.doi.org/10.1016/S0140-6736(05)67568-X; PMID: 16226616
   PubMed Web of Science ®Google Scholar
• Wang RX, Boland GJ, van Hattum J, de Gast GC. Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination. World J Gastroenterol 2004; 10:260 - 3; PMID: 14716835
   PubMed Web of Science ®Google Scholar
• Bybee JD, Rogers DE. The phagocytic activity of polymorphonucluar leukocytes obtained from patients with diabetes mellitus. J Lab Clin Med 1964; 64:1 - 13; PMID: 14192564
   PubMed Web of Science ®Google Scholar
• Bagdade JD, Nielson KL, Bulger RJ. Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am J Med Sci 1972; 263:451 - 6; http://dx.doi.org/10.1097/00000441-197206000-00005; PMID: 4403194
   PubMed Web of Science ®Google Scholar
• Stevens DL, Bryant AE, Huffman J, Thompson K, Allen RC. Analysis of circulating phagocyte activity measured by whole blood luminescence: correlations with clinical status. J Infect Dis 1994; 170:1463 - 72; http://dx.doi.org/10.1093/infdis/170.6.1463; PMID: 7995986
   PubMed Web of Science ®Google Scholar
• Saeed FA, Castle GE. Neutrophil chemiluminescence during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: implications for diabetic susceptibility to infections. Clin Diagn Lab Immunol 1998; 5:740 - 3; PMID: 9729546
   PubMedGoogle Scholar
• Gallacher SJ, Thomson G, Fraser WD, Fisher BM, Gemmell CG, MacCuish AC. Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control. Diabet Med 1995; 12:916 - 20; http://dx.doi.org/10.1111/j.1464-5491.1995.tb00396.x; PMID: 8846684
   PubMed Web of Science ®Google Scholar
• Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14:29 - 34; http://dx.doi.org/10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; PMID: 9017350
   PubMed Web of Science ®Google Scholar
• Foss-Freitas MC, Foss NT, Donadi EA, Foss MC. Effect of metabolic control on the in vitro proliferation of peripheral blood mononuclear cells in type 1 and type 2 diabetic patients. Sao Paulo Med J 2006; 124:219 - 22; http://dx.doi.org/10.1590/S1516-31802006000400009; PMID: 17086304
   PubMedGoogle Scholar
• Foss-Freitas MC, Foss NT, Donadi EA, Foss MC. In vitro TNF-alpha and IL-6 production by adherent peripheral blood mononuclear cells obtained from type 1 and type 2 diabetic patients evaluated according to the metabolic control. Ann N Y Acad Sci 2006; 1079:177 - 80; http://dx.doi.org/10.1196/annals.1375.027; PMID: 17130551
   PubMed Web of Science ®Google Scholar
• Foss-Freitas MC, Foss NT, Donadi EA, Foss MC. Effect of metabolic control on interferon-gamma and interleukin-10 production by peripheral blood mononuclear cells from type 1 and type 2 diabetic patients. Braz J Med Biol Res 2007; 40:671 - 7; http://dx.doi.org/10.1590/S0100-879X2006005000107; PMID: 17464429
   PubMed Web of Science ®Google Scholar
• Hudu SA, Malik YA, Niazlin MT, Harmal NS, Adnan A, Alshrari AS, Sekawi Z. Antibody and immune memory persistence post infant hepatitis B vaccination. Patient Prefer Adherence 2013; 7:981 - 6; http://dx.doi.org/10.2147/PPA.S49776; PMID: 24101865
   PubMed Web of Science ®Google Scholar
• Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Kuriyakose S, Leyssen M, Jacquet J-M. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat 2011; 18:369 - 75; http://dx.doi.org/10.1111/j.1365-2893.2010.01312.x; PMID: 20384962
   PubMed Web of Science ®Google Scholar
• Lu C-Y, Chiang B-L, Chi W-K, Chang M-H, Ni Y-H, Hsu H-M, Twu SJ, Su IJ, Huang LM, Lee CY. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004; 40:1415 - 20; http://dx.doi.org/10.1002/hep.20490; PMID: 15565627
   PubMed Web of Science ®Google Scholar
• Sugiyama M, Tanaka Y, Kurbanov F, Maruyama I, Shimada T, Takahashi S, Shirai T, Hino K, Sakaida I, Mizokami M. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology 2009; 136:652 - , e3; http://dx.doi.org/10.1053/j.gastro.2008.10.048; PMID: 19041311
   PubMed Web of Science ®Google Scholar
• Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000; 118:554 - 9; http://dx.doi.org/10.1016/S0016-5085(00)70261-7; PMID: 10702206
   PubMed Web of Science ®Google Scholar